Comparative Pathophysiology And Clinical Epidemiology Of Knowlesi Malaria
Funder
National Health and Medical Research Council
Funding Amount
$267,172.00
Summary
The simian parasite P. knowlesi is the most common cause of malaria in Malaysia and can cause severe and fatal disease. We are currently conducting a study of all malaria patients admitted to a tertiary referral hospital in Sabah, Malaysia. This will allow us to describe the epidemiological and clinical features of the hospitalised patients, including changes over time. We are also conducting novel pathophysiological studies which will allow us to understand how P. knowlesi causes sever disease.
Targeting The Human Immune Response To Bacterial Superantigens.
Funder
National Health and Medical Research Council
Funding Amount
$165,424.00
Summary
This research investigates the human immune response to infection with toxin producing bacteria. Toxins activate the human immune system which can lead to serious illness or the development of disease that can progress rapidly and be associated with high rates of morbidity and mortality. Investigating the harmful effects of infection with toxin producing bacteria in humans and the damage caused by their toxins is essential for the development of effective therapeutic strategies.
Combating Infectious Diseases: Eco-Epidemiology, Disease Mapping, And Travel Medicine
Funder
National Health and Medical Research Council
Funding Amount
$344,644.00
Summary
Infectious disease outbreaks are driven by complex interactions between humans, animals, vectors, and the environment. Globally, outbreaks have been increasing in frequency and magnitude, e.g. Ebola and SARS. There is an urgent need to improve public health intelligence by accurately identifying the causes, timing, and hotspots. This project will develop advanced modelling strategies for improving our understanding of outbreaks, and optimise public health interventions to protect human health.
The Stunting Risk Assessment Tool: Identifying Infants At High Risk Of Impaired Growth And Development In Resource Poor Settings.
Funder
National Health and Medical Research Council
Funding Amount
$344,644.00
Summary
Stunting is a neglected global health crisis. After the age of 2, irreversible health, developmental and economic consequences occur that are perpetuated across generations. Early risk prediction is key to more effective interventions. By determining the contribution of risk factors in pregnancy and early infancy, I propose to develop a tool that can be used by health workers to identify infants at high risk of stunting in early life, so that early preventive measures can be introduced.
Genomic Approaches To Understanding Tasmanian Devil Facial Tumor Disease
Funder
National Health and Medical Research Council
Funding Amount
$210,855.00
Summary
Devil facial tumor disease (DFTD) is an emerging infectious disease affecting Tasmanian devils. DFTD is a transmissible cancer, and results in the growth of large tumors usually on the face and mouth of affected animals. DFTD has led to the collapse of the Tasmanian devil population, and there is concern that the disease will drive devils to extinction in the wild within the next 20 years. I propose to use new genome sequencing technologies to discover genes responsible for DFTD.
A One Health Approach To Assessing The Threat Of Clostridium Difficile To Australia’s Biosecurity: A Genomic Investigation Of Human, Animal And Environmental Isolates
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Clostridium difficile is a bacterium that causes life-threatening diarrhoea in humans and animals and is a major public health issue in Australia. This project will study the genetic make-up of the bacterium and identify factors contributing to the emergence, evolution, and spread of C. difficile. This knowledge will be essential in guiding effective public health interventions and reducing deaths from C. difficile infection in humans and animals.
Emerging Infectious Neurological Diseases In Australia; From Enhanced Recognition To Improved Response
Funder
National Health and Medical Research Council
Funding Amount
$189,384.00
Summary
Infectious neurological diseases(IND) such as encephalitis are severe and frequently cause long term disability. New IND like Zika pose a real threat. During his PhD, Dr Britton identified outbreaks of encephalitis in children and described serious consequences. Here, Dr Britton proposes to extend his work across all ages, include other types of IND and explore novel methods to detect outbreaks. He will work with experts at leading national research centres in surveillance and infectious disease
Export Of Effector Proteins By P. Falciparum To The Infected Erythrocyte.
Funder
National Health and Medical Research Council
Funding Amount
$196,582.00
Summary
Infection by the malaria parasite has lethal consequences for humans. In order to survive the parasite exports hundreds of proteins to commandeer the erythrocyte. A translocon that mediates such export has been identified and important questions remain unanswered. In this research, I aim to determine the function of one of the major translocon components for export of proteins to the erythrocyte (EXP2) and through this process determine if it is a viable target for anti-malarial drug development ....Infection by the malaria parasite has lethal consequences for humans. In order to survive the parasite exports hundreds of proteins to commandeer the erythrocyte. A translocon that mediates such export has been identified and important questions remain unanswered. In this research, I aim to determine the function of one of the major translocon components for export of proteins to the erythrocyte (EXP2) and through this process determine if it is a viable target for anti-malarial drug development.Read moreRead less
This fellowship aims to develop evidence-based clinical and public health approaches to the control of multi-drug resistant tuberculosis. Projects include identifying optimal treatment approaches to drug resistant tuberculosis by using meta-analyses; analysing the cost-effectiveness of strategies to prevent drug resistant tuberculosis; understanding transmission of drug resistance within households and implementing a major clinical trial of antibiotic therapy to prevent the disease.